CIK: 1817160 - Address: C/o Nurix Therapeutics, Inc., 1700 Owens Street, Suite 205, San Francisco, CA 94158
26 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
7/30/24 19:06
7/30/24
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-7020.670-3-745D
4/30/24 18:33
4/30/24
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-2412.040-2-540D
1/30/24 18:52
1/30/24
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-197.990-2-636D
11/1/23 16:40
10/31/23
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-85.200-2-534D
8/1/23 16:26
7/31/23
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-189.650-2-630D
5/2/23 16:31
5/1/23
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-119.880-1-427D
2/1/23 16:15
1/30/23
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1711.780-1-623D
11/1/22 19:33
10/31/22
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1512.880-1-521D
8/2/22 17:45
8/1/22
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1915.670-1-619D
5/3/22 19:05
5/2/22
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1311.750-1-617D
1/4/22 16:19
1/3/22
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-5328.960-2-1114D
12/2/21 17:43
12/1/21
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1229.1300-314D
11/2/21 17:28
11/1/21
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1333.2400-314D
10/28/21 19:23
10/27/21
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1435.0000-314D
10/4/21 17:16
10/1/21
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1229.9200-314D
9/8/21 17:08
9/7/21
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-5635.000-2-1014D
9/2/21 16:22
9/1/21
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1332.3400-314D
8/3/21 17:39
8/2/21
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1231.2100-314D
7/2/21 16:03
7/1/21
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1126.7600-314D
6/2/21 16:49
6/1/21
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1127.7400-314D
5/4/21 16:27
5/3/21
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-2835.000-1-514D
4/6/21 16:04
4/5/21
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1435.0000-314D
4/2/21 17:22
4/1/21
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-1331.5500-314D
3/16/21 18:50
3/16/21
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-3645.000-1-514D
3/2/21 17:29
3/1/21
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-2935.950-1-514D
2/22/21 16:07
2/18/21
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHansen GwennCAOChief ScS.d-2936.270-1-612D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact